Positive basophil histamine release assay predicts insufficient response to standard-dosed omalizumab in patients with chronic spontaneous urticaria

MLA

Baumann, Katrine, et al. “Positive Basophil Histamine Release Assay Predicts Insufficient Response to Standard-Dosed Omalizumab in Patients with Chronic Spontaneous Urticaria.” Baumann , K , Jørgensen , A H R , Sørensen , J A , Zhang , D G , Ghazanfar , M N , Skov , P S , Woetmann , A , Vestergaard , C , Maurer , M & Thomsen , S F 2023 , ’ Positive Basophil Histamine Release Assay Predicts Insufficient Response to Standard-Dosed Omalizumab in Patients with Chronic Spontaneous Urticaria ’ , Clinical and Experimental Allergy , Vol. 53 , No. 12 , Pp. 1318-1321 , 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1439550662&authtype=sso&custid=ns315887.

APA

Baumann, K., Jørgensen, A. H. R., Sørensen, J. A., Zhang, D. G., Ghazanfar, M. N., Skov, P. S., Woetmann, A., Vestergaard, C., Maurer, M., & Thomsen, S. F. (2023). Positive basophil histamine release assay predicts insufficient response to standard-dosed omalizumab in patients with chronic spontaneous urticaria. Baumann , K , Jørgensen , A H R , Sørensen , J A , Zhang , D G , Ghazanfar , M N , Skov , P S , Woetmann , A , Vestergaard , C , Maurer , M & Thomsen , S F 2023 , ’ Positive Basophil Histamine Release Assay Predicts Insufficient Response to Standard-Dosed Omalizumab in Patients with Chronic Spontaneous Urticaria ’ , Clinical and Experimental Allergy , Vol. 53 , No. 12 , Pp. 1318-1321 .

Chicago

Baumann, Katrine, Astrid Helene Ravn Jørgensen, Jennifer Astrup Sørensen, Ditte Georgina Zhang, Misbah Noshela Ghazanfar, Per Stahl Skov, Anders Woetmann, Christian Vestergaard, Marcus Maurer, and Simon Francis Thomsen. 2023. “Positive Basophil Histamine Release Assay Predicts Insufficient Response to Standard-Dosed Omalizumab in Patients with Chronic Spontaneous Urticaria.” Baumann , K , Jørgensen , A H R , Sørensen , J A , Zhang , D G , Ghazanfar , M N , Skov , P S , Woetmann , A , Vestergaard , C , Maurer , M & Thomsen , S F 2023 , ’ Positive Basophil Histamine Release Assay Predicts Insufficient Response to Standard-Dosed Omalizumab in Patients with Chronic Spontaneous Urticaria ’ , Clinical and Experimental Allergy , Vol. 53 , No. 12 , Pp. 1318-1321 . http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1439550662&authtype=sso&custid=ns315887.